Aurora Cannabis Inc - Asset Resilience Ratio
Aurora Cannabis Inc (ACB) has an Asset Resilience Ratio of 13.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ACB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2025)
This chart shows how Aurora Cannabis Inc's Asset Resilience Ratio has changed over time. See Aurora Cannabis Inc net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Aurora Cannabis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ACB stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$56.36 Million | 7.27% |
| Short-term Investments | CA$52.09 Million | 6.72% |
| Total Liquid Assets | CA$108.45 Million | 13.99% |
Asset Resilience Insights
- Moderate Liquidity: Aurora Cannabis Inc has 13.99% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Aurora Cannabis Inc Industry Peers by Asset Resilience Ratio
Compare Aurora Cannabis Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 1.28% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Procter & Gamble Health Limited
NSE:PGHL |
Drug Manufacturers - Specialty & Generic | 33.01% |
Annual Asset Resilience Ratio for Aurora Cannabis Inc (2010–2025)
The table below shows the annual Asset Resilience Ratio data for Aurora Cannabis Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 16.24% | CA$138.47 Million ≈ $100.17 Million |
CA$852.67 Million ≈ $616.81 Million |
+2.23pp |
| 2024-03-31 | 14.01% | CA$117.47 Million ≈ $84.98 Million |
CA$838.67 Million ≈ $606.68 Million |
-11.36pp |
| 2023-03-31 | 25.36% | CA$234.94 Million ≈ $169.95 Million |
CA$926.32 Million ≈ $670.09 Million |
-15.13pp |
| 2022-03-31 | 40.50% | CA$439.14 Million ≈ $317.67 Million |
CA$1.08 Billion ≈ $784.41 Million |
+24.17pp |
| 2021-03-31 | 16.32% | CA$425.21 Million ≈ $307.59 Million |
CA$2.60 Billion ≈ $1.88 Billion |
+10.24pp |
| 2020-03-31 | 6.08% | CA$169.25 Million ≈ $122.43 Million |
CA$2.78 Billion ≈ $2.01 Billion |
+0.34pp |
| 2019-03-31 | 5.74% | CA$315.98 Million ≈ $228.57 Million |
CA$5.50 Billion ≈ $3.98 Billion |
-1.43pp |
| 2018-03-31 | 7.17% | CA$136.96 Million ≈ $99.08 Million |
CA$1.91 Billion ≈ $1.38 Billion |
-46.95pp |
| 2017-03-31 | 54.12% | CA$174.64 Million ≈ $126.33 Million |
CA$322.68 Million ≈ $233.42 Million |
+53.74pp |
| 2016-03-31 | 0.39% | CA$71.00K ≈ $51.36K |
CA$18.40 Million ≈ $13.31 Million |
+0.37pp |
| 2015-03-31 | 0.01% | CA$1.50K ≈ $1.09K |
CA$13.53 Million ≈ $9.78 Million |
-97.25pp |
| 2011-03-31 | 97.26% | CA$1.35 Million ≈ $976.57K |
CA$1.39 Million ≈ $1.00 Million |
+8.79pp |
| 2010-03-31 | 88.46% | CA$1.53 Million ≈ $1.11 Million |
CA$1.73 Million ≈ $1.25 Million |
-- |
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more